You are currently on the new version of our website. Access the old version .

160 Results Found

  • Article
  • Open Access
5 Citations
6,372 Views
15 Pages

A New Workflow to Generate Monoclonal Antibodies against Microorganisms

  • Markus Göthel,
  • Martin Listek,
  • Katrin Messerschmidt,
  • Anja Schlör,
  • Anja Hönow and
  • Katja Hanack

9 October 2021

Monoclonal antibodies are used worldwide as highly potent and efficient detection reagents for research and diagnostic applications. Nevertheless, the specific targeting of complex antigens such as whole microorganisms remains a challenge. To provide...

  • Article
  • Open Access
14 Citations
3,901 Views
11 Pages

17 May 2021

Despite improvement during the last ten years in the longevity of patients with metastatic clear cell renal cell carcinoma (mccRCC) the disease remains incurable. Hence, new therapeutic strategies are urgently needed. Relapse following anti-angiogeni...

  • Review
  • Open Access
22 Citations
6,704 Views
15 Pages

Epstein–Barr virus (EBV) mainly persists in B cells, which differentiate into antibody-producing cells, and thus, EBV has been implicated in autoimmune diseases. We aimed to describe the EBV reactivation and its relevance to autoimmune disease,...

  • Communication
  • Open Access
4 Citations
3,532 Views
8 Pages

Generation of Monoclonal Antibodies for Sensitive Detection of Pro-Inflammatory Protein S100A9

  • Eun-Jung Kim,
  • Gyu-Min Im,
  • Chang-Soo Lee,
  • Yun-Gon Kim,
  • Byoung Joon Ko,
  • Hee-Jin Jeong and
  • Byung-Gee Kim

19 May 2021

The calcium-binding protein S100A9 regulates inflammatory processes and the immune response. It is overexpressed in a variety of inflammatory and oncologic conditions. In this study, we produced a recombinant human S100A9 (hS100A9) antigen with high...

  • Article
  • Open Access
10 Citations
4,056 Views
13 Pages

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth

  • Hiroko Ishii,
  • Maram H. Zahra,
  • Atushi Takayanagi and
  • Masaharu Seno

8 February 2021

Cripto-1 is a member of the EGF-CFC/FRL1/Cryptic family and is involved in embryonic development and carcinogenesis. We designed a novel anti-Cripto-1 artificial antibody and assessed the recognition to the antigen and the potential to suppress the g...

  • Article
  • Open Access
14 Citations
6,287 Views
24 Pages

Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency

  • Indra Van Zundert,
  • Maria Bravo,
  • Olivier Deschaume,
  • Pierre Cybulski,
  • Carmen Bartic,
  • Johan Hofkens,
  • Hiroshi Uji-i,
  • Beatrice Fortuni and
  • Susana Rocha

The application of antibodies in nanomedicine is now standard practice in research since it represents an innovative approach to deliver chemotherapy agents selectively to tumors. The variety of targets or markers that are overexpressed in different...

  • Article
  • Open Access
9 Citations
8,199 Views
16 Pages

A Novel VHH Antibody Targeting the B Cell-Activating Factor for B-Cell Lymphoma

  • Wen Wu,
  • Shenghua Li,
  • Weijing Zhang,
  • Jian Sun,
  • Guangda Ren and
  • Quanchao Dong

28 May 2014

Objective: To construct an immune alpaca phage display library, in order to obtain a single domain anti-BAFF (B cell-activating factor) antibody. Methods: Using phage display technology, we constructed an immune alpaca phage display library, selected...

  • Article
  • Open Access
3 Citations
2,299 Views
15 Pages

A Novel High-Throughput Screening Method for a Human Multicentric Osteosarcoma-Specific Antibody and Biomarker Using a Phage Display-Derived Monoclonal Antibody

  • Takuma Hayashi,
  • Naoki Yamamoto,
  • Gene Kurosawa,
  • Kaori Tajima,
  • Mariko Kondo,
  • Noriko Hiramatsu,
  • Yu Kato,
  • Miho Tanaka,
  • Hisateru Yamaguchi and
  • Nobuyuki Fujita
  • + 2 authors

26 November 2022

Osteosarcoma is a malignant tumor that produces neoplastic bone or osteoid osteoma. In human multicentric osteosarcoma (HMOS), a unique variant of human osteosarcoma (HOS), multiple bone lesions occur simultaneously or asynchronously before lung meta...

  • Review
  • Open Access
10 Citations
7,277 Views
13 Pages

16 March 2023

The application of antibodies in cells was first shown in the early 1990s, and subsequently, the field of intracellular antibodies has expanded to encompass antibody fragments and their use in target validation and as engineered molecules that can be...

  • Article
  • Open Access
3 Citations
4,434 Views
10 Pages

12 November 2021

To develop efficient applications of monoclonal antibodies for therapeutic purposes, stereospecific recognition of the target antigens is needed. DNA immunization is one of the best methods for sensitizing B lymphocytes that can produce conformation-...

  • Article
  • Open Access
5 Citations
3,190 Views
13 Pages

Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies

  • Steffen Krohn,
  • Tosca Holtrop,
  • Arianne M. Brandsma,
  • Petra Moerer,
  • Maaike Nederend,
  • Nikos Darzentas,
  • Monika Brüggemann,
  • Katja Klausz,
  • Jeanette H. W. Leusen and
  • Matthias Peipp

12 April 2024

Antibodies that specifically bind to individual human fragment crystallizable γ receptors (FcγRs) are of interest as research tools in studying immune cell functions, as well as components in bispecific antibodies for immune cell engageme...

  • Article
  • Open Access
18 Citations
7,681 Views
12 Pages

Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail

  • Jeffrey W. Froude,
  • Andrew S. Herbert,
  • Thibaut Pelat,
  • Sebastian Miethe,
  • Samantha E. Zak,
  • Jennifer M. Brannan,
  • Russell R. Bakken,
  • Alexander R. Steiner,
  • Gang Yin and
  • John M. Dye
  • + 4 authors

26 May 2018

Sudan virus (SUDV) and Ebola viruses (EBOV) are both members of the Ebolavirus genus and have been sources of epidemics and outbreaks for several decades. We present here the generation and characterization of cross-reactive antibodies to both SUDV a...

  • Article
  • Open Access
2,289 Views
15 Pages

Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity

  • Moritz Bewarder,
  • Konstantinos Christofyllakis,
  • Milena Petersen,
  • Gerhard Held,
  • Sigrun Smola,
  • Gabi Carbon,
  • Birgit Bette,
  • Annika Link,
  • Maximilian Kiefer and
  • Frank Neumann
  • + 5 authors

30 November 2024

Cytomegalovirus (CMV) reactivation after stem cell or solid organ transplantation remains a major cause of morbidity and mortality in this setting. T-cell receptor (TCR)-like antibodies bind to intracellular peptides presented in major histocompatibi...

  • Article
  • Open Access
3,411 Views
12 Pages

26 September 2023

Respiratory Syncytial Virus (RSV) is a significant cause of lower respiratory tract infections in the young, the elderly, and in immunodeficient patients. As such, the virus represents an important cause of morbidity and mortality worldwide. Developm...

  • Article
  • Open Access
2 Citations
6,624 Views
21 Pages

11 March 2024

There is tremendous interest in the production of recombinant proteins, particularly bispecific antibodies and antibody–drug conjugates for research and therapeutic use. Here, we demonstrate a highly versatile plasmid system that allows the rap...

  • Review
  • Open Access
208 Citations
21,817 Views
22 Pages

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications

  • Nirnoy Dan,
  • Saini Setua,
  • Vivek K. Kashyap,
  • Sheema Khan,
  • Meena Jaggi,
  • Murali M. Yallapu and
  • Subhash C. Chauhan

Chemotherapy is one of the major therapeutic options for cancer treatment. Chemotherapy is often associated with a low therapeutic window due to its poor specificity towards tumor cells/tissues. Antibody-drug conjugate (ADC) technology may provide a...

  • Communication
  • Open Access
19 Citations
4,943 Views
10 Pages

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection

  • Alexandra Tauzin,
  • Gabrielle Gendron-Lepage,
  • Manon Nayrac,
  • Sai Priya Anand,
  • Catherine Bourassa,
  • Halima Medjahed,
  • Guillaume Goyette,
  • Mathieu Dubé,
  • Renée Bazin and
  • Andrés Finzi
  • + 1 author

4 March 2022

SARS-CoV-2 infection rapidly elicits anti-Spike antibodies whose quantity in plasma gradually declines upon resolution of symptoms. This decline is part of the evolution of an immune response leading to B cell differentiation into short-lived antibod...

  • Communication
  • Open Access
1,361 Views
25 Pages

Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen

  • Jaromír Vašíček,
  • Miroslav Bauer,
  • Eva Kontseková,
  • Andrej Baláži,
  • Andrea Svoradová,
  • Linda Dujíčková,
  • Eva Tvrdá,
  • Jakub Vozaf,
  • Peter Supuka and
  • Peter Chrenek

15 July 2025

The rabbit is a widely used experimental model for human translational research and stem cell therapy. Many studies have focused on rabbit mesenchymal stem cells from different biological sources for their possible application in regenerative medicin...

  • Article
  • Open Access
10 Citations
4,099 Views
15 Pages

Generation of Rat Monoclonal Antibody to Detect Hydrogen Sulfide and Polysulfides in Biological Samples

  • Shingo Kasamatsu,
  • Yuki Kakihana,
  • Taisei Koga,
  • Hisashi Yoshioka and
  • Hideshi Ihara

21 November 2020

Hydrogen sulfide (H2S) is endogenously produced by enzymes and via reactive persulfide/polysulfide degradation; it participates in a variety of biological processes under physiological and pathological conditions. H2S levels in biological fluids, suc...

  • Brief Report
  • Open Access
2 Citations
2,471 Views
14 Pages

Impact of Light-Chain Variants on the Expression of Therapeutic Monoclonal Antibodies in HEK293 and CHO Cells

  • Alexander Veber,
  • Dennis Lenau,
  • Polyniki Gkragkopoulou,
  • David Kornblüh Bauer,
  • Ingo Focken,
  • Wulf Dirk Leuschner,
  • Christian Beil,
  • Sandra Weil,
  • Ercole Rao and
  • Thomas Langer

Recombinantly produced monoclonal antibodies (mabs) belong to the fastest growing class of biotherapeutics. In humans, antibodies are classified into five different classes: IgA, IgD, IgE, IgG and IgM. Most of the therapeutic mabs used in the clinic...

  • Article
  • Open Access
8 Citations
4,551 Views
19 Pages

Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab

  • Katharina Stadlbauer,
  • Peter Andorfer,
  • Gerhard Stadlmayr,
  • Florian Rüker and
  • Gordana Wozniak-Knopp

Inhibition of complement activation via the overexpression of complement-regulatory proteins (CRPs), most notably CD46, CD55 and CD59, is an efficient mechanism of disguise of cancer cells from a host immune system. This phenomenon extends to counter...

  • Article
  • Open Access
2 Citations
4,371 Views
13 Pages

Platform-Specific Fc N-Glycan Profiles of an Antisperm Antibody

  • Ellena Nador,
  • Chaoshuang Xia,
  • Philip J. Santangelo,
  • Kevin J. Whaley,
  • Catherine E. Costello and
  • Deborah J. Anderson

IgG Fc N-glycosylation is necessary for effector functions and is an important component of quality control. The choice of antibody manufacturing platform has the potential to significantly influence the Fc glycans of an antibody and consequently alt...

  • Article
  • Open Access
21 Citations
5,665 Views
12 Pages

Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells

  • Dmitry Polikarpov,
  • Liuen Liang,
  • Andrew Care,
  • Anwar Sunna,
  • Douglas Campbell,
  • Bradley Walsh,
  • Irina Balalaeva,
  • Andrei Zvyagin,
  • David Gillatt and
  • Evgenii Guryev

3 December 2019

Bladder cancer is the ninth most common cancer worldwide. Due to a high risk of recurrence and progression of bladder cancer, every patient needs long-term surveillance, which includes regular cystoscopy, sometimes followed by a biopsy of suspicious...

  • Article
  • Open Access
9 Citations
7,372 Views
17 Pages

Detection and Quantification of ADP-Ribosylated RhoA/B by Monoclonal Antibody

  • Astrid Rohrbeck,
  • Viola Fühner,
  • Anke Schröder,
  • Sandra Hagemann,
  • Xuan-Khang Vu,
  • Sarah Berndt,
  • Michael Hust,
  • Andreas Pich and
  • Ingo Just

1 April 2016

Clostridium botulinum exoenzyme C3 is the prototype of C3-like ADP-ribosyltransferases that modify the GTPases RhoA, B, and C. C3 catalyzes the transfer of an ADP-ribose moiety from the co-substrate nicotinamide adenine dinucleotide (NAD) to asparagi...

  • Article
  • Open Access
8 Citations
4,769 Views
13 Pages

Affinity-Enhanced CTC-Capturing Hydrogel Microparticles Fabricated by Degassed Mold Lithography

  • Nak Jun Lee,
  • Sejung Maeng,
  • Hyeon Ung Kim,
  • Yoon Ho Roh,
  • Changhyun Hwang,
  • Jongjin Kim,
  • Ki-Tae Hwang and
  • Ki Wan Bong

21 January 2020

Technologies for the detection and isolation of circulating tumor cells (CTCs) are essential in liquid biopsy, a minimally invasive technique for early diagnosis and medical intervention in cancer patients. A promising method for CTC capture, using a...

  • Article
  • Open Access
1 Citations
2,465 Views
17 Pages

Antibody Mediated Intercommunication of Germinal Centers

  • Theinmozhi Arulraj,
  • Sebastian C. Binder and
  • Michael Meyer-Hermann

19 November 2022

Antibody diversification and selection of B cells occur in dynamic structures called germinal centers (GCs). Passively administered soluble antibodies regulate the GC response by masking the antigen displayed on follicular dendritic cells (FDCs). Thi...

  • Review
  • Open Access
9 Citations
5,809 Views
18 Pages

21 December 2023

The 80+ existing autoimmune disorders (ADs) affect billions with little prevention or treatment options, except for temporary symptomatic management, leading to enormous human suffering and a monumental financial burden. The autoantibodies formed in...

  • Article
  • Open Access
1,262 Views
23 Pages

Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice

  • Silviya Bradyanova,
  • Nikolina Mihaylova,
  • Nikola Ralchev,
  • Alexandra Kapogianni,
  • Ginka Cholakova,
  • Kalina Nikolova-Ganeva,
  • Ivanka Tsacheva and
  • Andrey Tchorbanov

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease characterized by tissue damage in multiple organs caused by autoantibodies and the resulting immune complexes. One possible way for complement system contribution to onse...

  • Review
  • Open Access
159 Citations
21,448 Views
31 Pages

21 January 2011

Ligands selected from phage-displayed random peptide libraries tend to be directed to biologically relevant sites on the surface of the target protein. Consequently, peptides derived from library screenings often modulate the target protein’s activit...

  • Article
  • Open Access
7 Citations
4,181 Views
18 Pages

Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama

  • Igor E. Eliseev,
  • Valeria M. Ukrainskaya,
  • Anna N. Yudenko,
  • Anna D. Mikushina,
  • Stanislav V. Shmakov,
  • Anastasiya I. Afremova,
  • Viktoria M. Ekimova,
  • Anna A. Vronskaia,
  • Nickolay A. Knyazev and
  • Olga V. Shamova

The human ErbB3 receptor confers resistance to the pharmacological inhibition of EGFR and HER2 receptor tyrosine kinases in cancer, which makes it an important therapeutic target. Several anti-ErbB3 monoclonal antibodies that are currently being deve...

  • Article
  • Open Access
8 Citations
8,052 Views
22 Pages

By-Passing Large Screening Experiments Using Sequencing as a Tool to Identify scFv Fragments Targeting Atherosclerotic Lesions in a Novel In Vivo Phage Display Selection

  • Kamel Deramchia,
  • Marie-Josee Jacobin-Valat,
  • Jeanny Laroche-Traineau,
  • Stephane Bonetto,
  • Stephane Sanchez,
  • Pierre Dos Santos,
  • Philippe Massot,
  • Jean-Michel Franconi,
  • Pierre Martineau and
  • Gisele Clofent-Sanchez

7 June 2012

Atherosclerosis is a chronic, progressive inflammatory disease that may develop into vulnerable lesions leading to thrombosis. To interrogate the molecular components involved in this process, single-chain variable fragments (scFvs) from a semi-synth...

  • Article
  • Open Access
2 Citations
3,172 Views
16 Pages

An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules

  • Giulia Tomaino,
  • Camilla Pantaleoni,
  • Annalisa D’Urzo,
  • Carlo Santambrogio,
  • Filippo Testa,
  • Matilde Ciprandi,
  • Davide Cotugno,
  • Gianni Frascotti,
  • Marco Vanoni and
  • Paolo Tortora

Vaults are eukaryotic ribonucleoproteins consisting of 78 copies of the major vault protein (MVP), which assemble into a nanoparticle with an about 60 nm volume-based size, enclosing other proteins and RNAs. Regardless of their physiological role(s),...

  • Article
  • Open Access
11 Citations
7,192 Views
14 Pages

13 December 2021

Beta toxin (CPB) is a small hemolysin beta pore-forming toxin (β-PFT) produced by Clostridium perfringens type C. It plays a central role in the pathogenesis of necro-hemorrhagic enteritis in young animals and humans via targeting intestinal end...

  • Review
  • Open Access
28 Citations
5,583 Views
16 Pages

Therapeutic Applications of Aptamers

  • George Santarpia and
  • Eric Carnes

Affinity reagents, or target-binding molecules, are quite versatile and are major workhorses in molecular biology and medicine. Antibodies are the most famous and frequently used type and they have been used for a wide range of applications, includin...

  • Article
  • Open Access
16 Citations
7,217 Views
15 Pages

Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis

  • Eszter Szarka,
  • Petra Aradi,
  • Krisztina Huber,
  • Judit Pozsgay,
  • Lili Végh,
  • Anna Magyar,
  • Gergő Gyulai,
  • György Nagy,
  • Bernadette Rojkovich and
  • Gabriella Sármay
  • + 2 authors

Background: In rheumatoid arthritis (RA), anti-citrullinated protein/peptide antibodies (ACPAs) are responsible for disease onset and progression, however, our knowledge is limited on ligand binding affinities of autoantibodies with different citrull...

  • Article
  • Open Access
6 Citations
3,021 Views
17 Pages

Selective Silencing of Disease-Associated B Lymphocytes from Hashimoto’s Thyroiditis Patients by Chimeric Protein Molecules

  • Nikola Ralchev Ralchev,
  • Aleksandar Mishel Markovski,
  • Inna Angelova Yankova,
  • Iliyan Konstantinov Manoylov,
  • Irini Atanas Doytchinova,
  • Nikolina Mihaylova Mihaylova,
  • Alexander Dimitrov Shinkov and
  • Andrey Ivanov Tchorbanov

1 December 2022

Hashimoto’s thyroiditis is one of the most common endocrine disorders, affecting up to 20% of the adult population. No treatment or prevention exists except hormonal substitution for hypothyroidism. We hypothesize that it may be possible to sel...

  • Article
  • Open Access
4 Citations
3,487 Views
14 Pages

The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody

  • Daniela Luz,
  • Fernando D. Gómez,
  • Raíssa L. Ferreira,
  • Bruna S. Melo,
  • Beatriz E. C. Guth,
  • Wagner Quintilio,
  • Ana Maria Moro,
  • Agostina Presta,
  • Flavia Sacerdoti and
  • Roxane M. F. Piazza
  • + 4 authors

22 November 2021

Hemolytic Uremic Syndrome (HUS) associated with Shiga-toxigenic Escherichia coli (STEC) infections is the principal cause of acute renal injury in pediatric age groups. Shiga toxin type 2 (Stx2) has in vitro cytotoxic effects on kidney cells, includi...

  • Article
  • Open Access
8 Citations
5,691 Views
15 Pages

ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling

  • Kurt Ballmer-Hofer,
  • Caroline A.C. Hyde,
  • Thomas Schleier and
  • Dragana Avramovic

Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) is the main mediator of angiogenic signaling in endothelial cells and a primary responder to VEGF. VEGF dependent VEGFR-2 activation regulates endothelial cell migration and proliferation, as we...

  • Article
  • Open Access
3 Citations
4,054 Views
12 Pages

The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice

  • Kangwei Xu,
  • Jing Li,
  • Xu Lu,
  • Xiaoqin Ge,
  • Kaiqin Wang,
  • Jiahao Wang,
  • Zhizhong Qiao,
  • Yaru Quan and
  • Changgui Li

7 January 2024

The continuous evolution and mutation of SARS-CoV-2 have highlighted the need for more effective vaccines. In this study, CpG, MF59-like, and Alum adjuvant Delta strain inactivated SARS-CoV-2 vaccines were prepared, and the immunogenicity of these va...

  • Article
  • Open Access
2,172 Views
23 Pages

Suppression of Pathological Allergen-Specific B Cells by Protein-Engineered Molecules in a Mouse Model of Chronic House Dust Mite Allergy

  • Nikola Ralchev,
  • Silviya Bradyanova,
  • Nikola Kerekov,
  • Andrey Tchorbanov and
  • Nikolina Mihaylova

20 December 2024

Der p1 is one of the major allergens causing house dust mite (HDM) allergy. Pathological Der p1-specific B cells play a key role in allergic inflammation as producers of allergen-specific antibodies. Crosslinking the inhibitory FcγRIIb with the...

  • Article
  • Open Access
16 Citations
6,256 Views
15 Pages

A Metabolomics Approach to Increasing Chinese Hamster Ovary (CHO) Cell Productivity

  • Grace Yao,
  • Kathryn Aron,
  • Michael Borys,
  • Zhengjian Li,
  • Girish Pendse and
  • Kyongbum Lee

30 November 2021

Much progress has been made in improving the viable cell density of bioreactor cultures in monoclonal antibody production from Chinese hamster ovary (CHO) cells; however, specific productivity (qP) has not been increased to the same degree. In this w...

  • Article
  • Open Access
2 Citations
3,558 Views
20 Pages

31 May 2023

Vaccines trigger an immunological response that includes B and T cells, with B cells producing antibodies. SARS-CoV-2 immunity weakens over time after vaccination. Discovering key changes in antigen-reactive antibodies over time after vaccination cou...

  • Brief Report
  • Open Access
1 Citations
2,312 Views
8 Pages

Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review

  • Franz Tatzber,
  • Willibald Wonisch,
  • Ulrike Resch,
  • Wolfgang Strohmaier,
  • Meinrad Lindschinger,
  • Sabrina Mörkl and
  • Gerhard Cvirn

14 June 2023

There is little doubt that final victories over pandemics, such as COVID-19, are attributed to herd immunity, either through post-disease convalescence or active immunization of a high percentage of the world’s population with vaccines, which d...

  • Article
  • Open Access
27 Citations
7,758 Views
22 Pages

Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library

  • Han Wang,
  • Rui Yu,
  • Ting Fang,
  • Ting Yu,
  • Xiangyang Chi,
  • Xiaopeng Zhang,
  • Shuling Liu,
  • Ling Fu,
  • Changming Yu and
  • Wei Chen

11 September 2016

Tetanus neurotoxin (TeNT) produced by Clostridium tetani is one of the most poisonous protein substances. Neutralizing antibodies against TeNT can effectively prevent and cure toxicosis. Using purified Hc fragments of TeNT (TeNT-Hc) as an antigen, th...

  • Article
  • Open Access
10 Citations
3,937 Views
15 Pages

Immunomodulatory Potential of the Industrialized Houttuynia cordata Fermentation Product In Vitro and in Wistar Rats

  • Suppawit Utaiwat,
  • Gulsiri Senawong,
  • Kanoknan Khongsukwiwat,
  • Khanutsanan Woranam,
  • Jintana Sattayasai and
  • Thanaset Senawong

26 October 2021

Houttuynia cordata fermentation products (HCFPs) are produced and widely used as dietary supplements for health and immune support. However, the effect on immune function for these products has not been clearly demonstrated. In this study, soluble fr...

  • Article
  • Open Access
3 Citations
2,936 Views
11 Pages

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection

  • Boonlert Lumlertdacha,
  • Bancha Mahong,
  • Kaewta Rattanapisit,
  • Christine Joy I. Bulaon,
  • Thiravat Hemachudha and
  • Waranyoo Phoolcharoen

17 August 2023

Rabies encephalitis is a fatal zoonotic viral disease caused by the neurotropic rabies virus. It remains a major public health concern as it causes almost 100% fatality and has no effective medication after the onset of the disease. However, this ill...

  • Review
  • Open Access
15 Citations
6,767 Views
31 Pages

Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma

  • Fleury Augustin Nsole Biteghe,
  • Nyangone Ekome Toung Chalomie,
  • Neelakshi Mungra,
  • Guillaume Vignaux,
  • Nan Gao,
  • Aurelia Vergeade,
  • Ambrose Okem,
  • Krupa Naran,
  • Jean De La Croix Ndong and
  • Stefan Barth

Melanoma is the least common form of skin cancer and is associated with the highest mortality. Where melanoma is mostly unresponsive to conventional therapies (e.g., chemotherapy), BRAF inhibitor treatment has shown improved therapeutic outcomes. Pho...

  • Article
  • Open Access
1 Citations
3,114 Views
20 Pages

A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities

  • Leif Håkansson,
  • Pontus Dunér,
  • Erik Broströmer,
  • Bengt Gustavsson,
  • Yvonne Wettergren,
  • Bijar Ghafouri,
  • Annika Håkansson and
  • Birgitta Clinchy

24 October 2024

Background: Interleukin-6 is dysregulated in multiple pathological conditions, e.g., cancer and inflammatory diseases. Aim: To investigate new mechanisms for the regulation of pathological IL-6 production. Methods: PBMCs (peripheral blood mononuclear...

  • Review
  • Open Access
26 Citations
8,583 Views
21 Pages

21 January 2015

Immunoglobulins are molecules produced by activated B cells and plasma cells in response to exposure to antigens. Upon antigen exposure, these molecules are secreted allowing the immune system to recognize and effectively respond to a myriad of patho...

  • Article
  • Open Access
24 Citations
13,749 Views
12 Pages

Biomimetic Yeast Cell Typing—Application of QCMs

  • Karin Seidler,
  • Miroslava Polreichová,
  • Peter A. Lieberzeit and
  • Franz L. Dickert

16 October 2009

Artificial antibodies represent a key factor in the generation of sensing systems for the selective detection of bioanalytes of variable sizes. With biomimetic surfaces, the important model organism Saccharomyces cerevisiae and several of its growth...

of 4